We have observed
13 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 19, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
METHOD FOR INCREASING ETEC CS6 ANTIGEN PRESENTATION ON CELL SURFACE AND PRODUCTS OBTAINABLE THEREOF
MUTANT CELLS FOR PROTEIN SECRETION AND LIGNOCELLULOSE DEGRADATION
DETECTION OF SAXITOXIN-PRODUCING DINOFLAGELLATES
ZSCAN4 AS A MARKER FOR PANCREATIC STEM CELLS AND PROGENITOR CELLS AND USE THEREOF
METHODS OF TREATING CANCER COMPRISING TARGETING NQO1
DROUGHT RESISTANT PLANTS AND METHODS FOR MAKING THE SAME USING TRANSCRIPTIONAL REGULATORS
Inhibitors of focal adhesion kinase
COMPOSITIONS AND METHODS FOR ENHANCING THE PLURIPOTENCY OF STEM CELLS
USE OF ZSCAN4 AND ZSCAN4-DEPENDENT GENES FOR DIRECT REPROGRAMMING OF SOMATIC CELLS
THERMOSTABLE C. BESCII ENZYMES
ENHANCED CELLODEXTRIN METABOLISM
NOVEL BIOMARKER AND USES THEREOF IN DIAGNOSIS, TREATMENT OF AUTISM